A Look Under the Rug at the Savvy Penetration of Europe’s Cannabis Market by Supreme Heights
CBD September 4, 2019
Ryan Allway September 4th, 2019 App, Exclusive, News, Top Story As the nascent European legal cannabis market emerges, Canadian companies that have cut their teeth in their home markets are taking that experience overseas to capitalize on a much larger market opportunity. The Supreme Cannabis Company Inc. (TSX: FIRE)... Read more
Want a Powerplay Cannabis Brand? Know Your Consumer
CBD September 3, 2019
Ash Stringer September 3rd, 2019 App, Exclusive, News, Top Story With recreational or medical marijuana allowed in 33 U.S. states, about 224 million people now have legal access to cannabis. An April Hill-HarrisX poll showed that 84% of Americans now support legalizing marijuana, including 42% of respondents expressing their... Read more
Ash Stringer August 26th, 2019 App, Exclusive, News, Top News In a cannabis market forecast by Grand View Research to reach $66.3 billion by the end of 2025, companies of all sizes are elbowing each other for market share. At Sublime Canna, the model is to avoid the scrum,... Read more
Ryan Allway August 15th, 2019 App, Exclusive, News, Top News While still in its infancy, the cannabis industry has reached an inflection point where some clear separation is happening between companies. To use some old axioms, “The cream is rising to the top” and “The wheat is being separated... Read more
Ash Stringer August 14th, 2019 App, Exclusive, News, Top Story When you’ve got something great, it may take a little bit of time for people to learn about it, but once word starts getting around, it can yield a windfall of interest. That’s the case with Lexaria Bioscience Corp.... Read more
XPhyto Therapeutics Debuts on CSE Under Ticker XPHY
August 6, 2019
Ryan Allway August 6th, 2019 App, Exclusive, News, Top News After about two years of building relationships with exceptional partners and positioning itself in Canada and Europe, XPhyto Therapeutics (CSE: XPHY) was ready to become a public company. That happened Tuesday morning, with trading beginning on the Canadian Securities... Read more
Ash Stringer August 5th, 2019 App, Exclusive, News, Top Story As the cannabis market moves from the back alley to the boardroom, we are gaining an increasing appreciation for the role genetics play in developing distinct varieties with unique medical and commercial application. As the cannabis market matures, the... Read more
Ryan Allway August 2nd, 2019 Exclusive, News, Top Story, Uncategorized Only days after announcing that its wholly owned subsidiary was awarded a German cannabis and cultivation and extraction licence, XPhyto Therapeutics is ready to enter the public domain. With a final prospectus filed with the British Columbia Securities Commission,... Read more
Ryan Allway August 1st, 2019 App, Exclusive, News, Top Story The cannabis industry is quickly moving through a well-known cycle for emerging markets. Like Google in the tech industry, early market entrants that have become successful in a given subset of the fragmented market are starting to look to... Read more
Synthetic Cannabinoids: The New Age of Medical Marijuana
July 22, 2019
Ryan Allway July 22nd, 2019 App, Exclusive, News, Top News Believe it or not, the world’s first blockbuster drug is still one of the most commonly used today. Acetylsalicylic acid, better known as Aspirin®, is a synthetic derivative of the natural substance salicylic acid, an extract from the bark... Read more
